Compare CTRE & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTRE | ONTO |
|---|---|---|
| Founded | 2013 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Machinery/Components |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.4B |
| IPO Year | 2013 | 1995 |
| Metric | CTRE | ONTO |
|---|---|---|
| Price | $39.34 | $255.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $42.40 | ★ $290.63 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 96.25 | N/A |
| EPS | 0.36 | ★ 0.67 |
| Revenue | ★ $476,393,000.00 | N/A |
| Revenue This Year | $5.97 | $26.63 |
| Revenue Next Year | $13.39 | $16.26 |
| P/E Ratio | ★ $113.75 | $383.37 |
| Revenue Growth | ★ 60.79 | N/A |
| 52 Week Low | $27.82 | $89.40 |
| 52 Week High | $43.08 | $316.00 |
| Indicator | CTRE | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 43.83 |
| Support Level | $38.59 | $238.12 |
| Resistance Level | $40.36 | $312.85 |
| Average True Range (ATR) | 0.90 | 13.45 |
| MACD | -0.22 | -3.13 |
| Stochastic Oscillator | 2.62 | 36.05 |
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.